Markets

Market Nav

News Details

13/02/2026 18:40

Samrat Pharma posts Q3 net loss of Rs 0.46 cr

The company reported standalone net loss during the quarter stood at Rs 0.46 crore compared to net profit of Rs 2.78 crore in the previous year quarter.ÿ

Net revenue of the company declined by 0.36 per cent at Rs 63.43 crore in October-December quarter of this fiscal as against Rs 63.66 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 7.72 per cent to Rs 64.08 crore from Rs 59.49 crore in year ago period.

Other Income grew by 0.00 per cent at Rs 0.40 crore versus (Dec'24 Rs 0.00 crore).

Operating Profit slipped by 115.83 per cent to Rs -0.66 crore as against Rs 4.17 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 115.88 per cent in December quarter.

Interest grew by 30.00 per cent y-o-y to Rs 0.13 crore, while Taxation decreased by 109.73 per cent at Rs -0.11 crore (Dec'24 Rs 1.13 crore).